Literature DB >> 20153515

Formation of procoagulant microparticles and properties.

Jean-Marie Freyssinet1, Florence Toti.   

Abstract

The platelet procoagulant response consists of providing a catalytic surface where vitamin K-dependent clotting factors can interact with cofactors to form the characteristic enzyme complexes of the cascade culminating in the generation of sufficient thrombin for effective hemostasis. The essential element allowing such a local concentration is the anionic aminophospholipid phosphatidylserine, sequestered in the inner leaflet of the plasma membrane of resting cells but swiftly translocated to the outer leaflet after stimulation. Phosphatidylserine egress is followed by the shedding of membrane fragments, the so-called microparticles or microvesicles, also endowed with procoagulant properties more particularly when they harbor tissue factor, the major initiator of blood coagulation reactions. Furthermore, because microparticles hijack a number of membrane and cytoplasmic components from the cells they derive, they can elicit various responses in proximal or remote cells they interact with and can therefore be viewed as intercellular "macromessengers". Although several regulatory mechanisms have been proposed, the main actors responsible for the whole process of phosphatidylserine transmembrane redistribution and subsequent microparticle release remain to be identified. Copyright (c) 2009 Elsevier Ltd. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20153515     DOI: 10.1016/j.thromres.2010.01.036

Source DB:  PubMed          Journal:  Thromb Res        ISSN: 0049-3848            Impact factor:   3.944


  41 in total

1.  Microparticles during sepsis: target, canary or cure?

Authors:  Lara Zafrani; Can Ince; Peter S T Yuen
Journal:  Intensive Care Med       Date:  2013-08-08       Impact factor: 17.440

Review 2.  The Platelet Lifeline to Cancer: Challenges and Opportunities.

Authors:  Monika Haemmerle; Rebecca L Stone; David G Menter; Vahid Afshar-Kharghan; Anil K Sood
Journal:  Cancer Cell       Date:  2018-04-12       Impact factor: 31.743

Review 3.  Microparticles and cardiovascular diseases.

Authors:  Christos Voukalis; Eduard Shantsila; Gregory Y H Lip
Journal:  Ann Med       Date:  2019-06-17       Impact factor: 4.709

4.  Calpastatin controls polymicrobial sepsis by limiting procoagulant microparticle release.

Authors:  Lara Zafrani; Grigoris Gerotziafas; Colleen Byrnes; Xuzhen Hu; Joelle Perez; Charlène Lévi; Sandrine Placier; Emmanuel Letavernier; Asada Leelahavanichkul; Jean-philippe Haymann; Ismail Elalamy; Jeffrey L Miller; Robert A Star; Peter S T Yuen; Laurent Baud
Journal:  Am J Respir Crit Care Med       Date:  2012-01-20       Impact factor: 21.405

5.  Neutrophils generate microparticles during exposure to inert gases due to cytoskeletal oxidative stress.

Authors:  Stephen R Thom; Veena M Bhopale; Ming Yang
Journal:  J Biol Chem       Date:  2014-05-27       Impact factor: 5.157

6.  Neutrophil derived microparticles increase mortality and the counter-inflammatory response in a murine model of sepsis.

Authors:  Bobby L Johnson; Emily F Midura; Priya S Prakash; Teresa C Rice; Natalia Kunz; Kathrin Kalies; Charles C Caldwell
Journal:  Biochim Biophys Acta Mol Basis Dis       Date:  2017-01-17       Impact factor: 5.187

Review 7.  Contribution of platelets to tumour metastasis.

Authors:  Laurie J Gay; Brunhilde Felding-Habermann
Journal:  Nat Rev Cancer       Date:  2011-02       Impact factor: 60.716

8.  Characterization of platelet aminophospholipid externalization reveals fatty acids as molecular determinants that regulate coagulation.

Authors:  Stephen R Clark; Christopher P Thomas; Victoria J Hammond; Maceler Aldrovandi; Gavin W Wilkinson; Keith W Hart; Robert C Murphy; Peter W Collins; Valerie B O'Donnell
Journal:  Proc Natl Acad Sci U S A       Date:  2013-03-25       Impact factor: 11.205

Review 9.  Neutrophil derived microvesicles: emerging role of a key mediator to the immune response.

Authors:  Bobby L Johnson; Josh W Kuethe; Charles C Caldwell
Journal:  Endocr Metab Immune Disord Drug Targets       Date:  2014       Impact factor: 2.895

10.  Fas-induced apoptosis increases hepatocyte tissue factor procoagulant activity in vitro and in vivo.

Authors:  Michelle Lopez; Anna K Kopec; Nikita Joshi; Julia E Geddings; Holly Cline; Keara L Towery; Cheryl E Rockwell; Nigel Mackman; James P Luyendyk
Journal:  Toxicol Sci       Date:  2014-07-11       Impact factor: 4.849

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.